The meeting reviewed recent data collections for STI, including the 1990–2009 data, and discussed the data presentation, differences across the EU/EEA and trends.
Following a request by the Romanian government, ECDC conducted a second follow-up country visit to Romania covering HIV, sexually transmitted infections (STIs) and hepatitis B and C from 11–13 May 2011.
The results of two clinical studies, PROUD and IPERGAY, suggests that the use of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) is an effective HIV prevention tool for Europe.
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
This report is an update on the status of the HIV response in the European Union/European Economic Area, as part of ECDC's commitment to monitoring the implementation of the Dublin Declaration in Europe and Central Asia.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.